Methylation of specific CpG sites in the P2 promoter of parathyroid hormone-related protein determines the invasive potential of breast cancer cell lines

Epigenetics

Volumn 6, Issue 8, 2011, Pages 1035-1046

  Tost, Jörg ^a,b   Hamzaoui, Hinda ^c   Busato, Florence ^a   Neyret, Aymeric ^c   Mourah, Samia ^d   Dupont, Jean Michel ^c,e   Bouizar, Zhor ^f,g  

^a CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

^c INSTITUT COCHIN   (France)

^d INSERM   (France)

^e Hôpital Cochin ^*  (France)

^f HÔPITAL ROBERT DEBRÉ   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Azacytidine; Breast cancer; Cell lines; DNA methylation; Metastasis; Parathyroid hormone related protein; Trichostatin A

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; PARATHYROID HORMONE RELATED PROTEIN; TRICHOSTATIN A;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BREAST CELL; BREAST EPITHELIUM; CANCER CELL; CARCINOGENESIS; CPG ISLAND; DEACETYLATION; DNA FLANKING REGION; DNA METHYLATION; EPIGENETICS; EPITHELIUM CELL; EXON; GENETIC VARIABILITY; HISTONE ACETYLATION; HUMAN; HUMAN CELL; INTRON; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION;

EID: 79961231633     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.8.16077     Document Type: Article

References (50)

1. Murray TM, Rao LG, Divieti P, Bringhurst FR. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr Rev 2005; 26:78-113.
2. Foley J, Dann P, Hong J, Cosgrove J, Dreyer B, Rimm D, et al. Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development. Development 2001; 128:513-25.
3. Bouizar Z, Spyratos F, De vernejoul MC. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis. J Bone Miner Res 1999; 14:406-14.
4. Bouizar Z, Spyratos F, Deytieux S, de Vernejoul MC, Jullienne A. Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res 1993; 53:5076-8.
5. Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 1996; 98:1544-9.
6. Liao J, McCauley LK,. Skeletal metastasis: Established and emerging roles of parathyroid hormone relat- ed protein (PTHrP). Cancer Metastasis Rev 2006 25:559-71.
7. Rizk-Rabin M, Assie G, Rene-Corail F, Perlemoine K Hamzaoui H, Tissier F, et al. Differential expression of parathyroid hormone-related protein in adrenocortica tumors: autocrine/paracrine effects on the growth and signaling pathways in H295R cells. Cancer Epidemio Biomarkers Prev 2008; 17:2275-85.
8. Gilmore JL, Scott JA, Bouizar Z, Robling A, Pitfield SE, Riese DJ, 2nd, et al. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells Breast Cancer Res Treat 2008; 110:493-505.
9. Van den Eynden GG, Neyret A, Fumey G, Rizk-Rabin M, Vermeulen PB, Bouizar Z, et al. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refrac- tory hypercalcemia due to a pancreatic neuroendocrine tumor. Bone 2007; 40:1166-71.
10. Bundred NJ, Walker RA, Ratcliffe WA, Warwick J Morrison JM, Ratcliffe JG. Parathyroid hormone related protein and skeletal morbidity in breast cancer Eur J Cancer 1992; 28:690-2.
11. Thomas RJ, Guise TA, Yin JJ, Elliott J, Horwood NJ Martin TJ, et al. Breast cancer cells interact with osteo-blasts to support osteoclast formation. Endocrinology 1999; 140:4451-8.
12. Yasuda T, Banville D, Hendy GN, Goltzman D. Characterization of the human parathyroid hormone- like peptide gene. Functional and evolutionary aspects. J Biol Chem 1989; 264:7720-5.
13. Brandt DW, Bruns ME, Bruns DE, Ferguson JE, 2nd, Burton DW, Deftos LJ. The parathyroid hormone-related protein (PTHrP) gene preferentially utilizes a GC-rich promoter and the PTHrP 1-139 coding pathway in normal human amnion. Biochem Biophys Res Commun 1992; 189:938-43.
14. Brandt DW, Wachsman W, Deftos LJ. Parathyroid hor- mone-like protein: alternative messenger RNA splicing pathways in human cancer cell lines. Cancer Res 1994; 54:850-3.
15. Campos RV, Wang C, Drucker DJ. Regulation of para- thyroid hormone-related peptide (PTHrP) gene tran- scription: cell- and tissue-specific promoter utilization mediated by multiple positive and negative cis-acting DNA elements. Mol Endocrinol 1992; 6:1642-52.
16. Mangin M, Ikeda K, Dreyer BE, Broadus AE. Isolation and characterization of the human parathyroid hor- mone-like peptide gene. Proc Natl Acad Sci USA 1989; 86:2408-12.
17. Mangin M, Ikeda K, Dreyer BE, Broadus AE. Identification of an up-stream promoter of the human parathyroid hormone-related peptide gene. Mol Endocrinol 1990; 4:851-8.
18. Southby J, Murphy LM, Martin TJ, Gillespie MT Cell-specific and regulator-induced promoter usage and messenger ribonucleic acid splicing for parathyroid hormone-related protein. Endocrinology 1996; 137:1349-57.
19. Southby J, O'Keeffe LM, Martin TJ, Gillespie MT Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumours. Br J Cancer 1995; 72:702-7.
20. Cataisson C, Gordon J, Roussiere M, Abdalkhani A, Lindemann R, Dittmer J, et al. Ets-1 activates parathyroid hormone-related protein gene expression in tumorigenic breast epithelial cells. Mol Cell Endocrinol 2003; 204:155-68.
21. Hamzaoui H, Rizk-Rabin M, Gordon J, Offutt C, Bertherat J, Bouizar Z. PTHrP P3 promoter activity in breast cancer cell lines: role of Ets1 and CBP (CREB binding protein). Mol Cell Endocrinol 2007; 268:75-84.
22. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683-92.
23. Vasavada RC, Wysolmerski JJ, Broadus AE, Philbrick WM. Identification and characterization of a GC-rich promoter of the human parathyroid hormone-related peptide gene. Mol Endocrinol 1993; 7:273-82.
24. Holt EH, Vasavada RC, Bander NH, Broadus AE, Philbrick WM. Region-specific methylation of the parathyroid hormone-related peptide gene determines its expression in human renal carcinoma cell lines. J Biol Chem 1993; 268:20639-45.
25. Ganderton RH, Briggs RS. CpG island methylation and promoter usage in the parathyroid hormone- related protein gene of cultured lung cells. Biochim Biophys Acta 1997; 1352:303-10.
26. Berthon P, Goubin G, Dutrillaux B, Degeorges A, Faille A, Gespach C, et al. Single-steep transformation of human breast epithelial cells by SV40 large T oncogene. Int J Cancer 1992; 52:92-7.
27. Cataisson C, Lieberherr M, Cros M, Gauville C, Graulet AM, Cotton J, et al. Parathyroid hormone-related peptide stimulates proliferation of highly tumorigenic human SV40-immortalized breast epithelial cells. J Bone Miner Res 2000; 15:2129-39.
28. Tost J, Gut IG. DNA methylation analysis by pyrose-quencing. Nat Protoc 2007; 2:2265-75.
29. Akino K, Ohtsuru A, Yano H, Ozeki S, Namba H, Nakashima M, et al. Antisense inhibition of parathyroid hormone-related peptide gene expression reduces malignant pituitary tumor progression and metastases in the rat. Cancer Res 1996; 56:77-86.
30. Linforth R, Anderson N, Hoey R, Nolan T, Downey S, Brady G, et al. Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival. Clin Cancer Res 2002; 8:3172-7.
31. Yoshida A, Nakamura Y, Shimizu A, Harada M, Kameda Y, Nagano A, et al. Significance of the parathyroid hormone-related protein expression in breast carcinoma. Breast Cancer 2000; 7:215-20.
32. Surowiak P, Dziegiel P, Matkowski R, Sopel M, Wojnar A, Kornafel J, et al. Prognostic value of immunocy-tochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course. Virchows Arch 2003; 442:245-51.
33. Henderson MA, Danks JA, Slavin JL, Byrnes GB, Choong PF, Spillane JB, et al. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. Cancer Res 2006; 66:2250-6.
34. Richard V, Rosol TJ, Foley J. PTHrP gene expression in cancer: do all paths lead to Ets? Crit Rev Eukaryot Gene Expr 2005; 15:115-32.
35. Nadella MV, Dirksen WP, Nadella KS, Shu S, Cheng AS, Morgenstern JA, et al. Transcriptional regulation of parathyroid hormone-related protein promoter P2 by NFkappaB in adult T-cell leukemia/lymphoma. Leukemia 2007; 21:1752-62.
36. Agrawal A, Murphy RF, Agrawal DK. DNA methyla- tion in breast and colorectal cancers. Mod Pathol 2007; 20:711-21.
37. Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene 2002; 21:5462-82.
38. Ganderton RH, Briggs RS. Increased upstream meth-ylation has no influence on the overexpression of the parathyroid hormone-related protein gene in squa-mous cell carcinoma of the lung. Eur J Cancer 2000; 36:2128-36.
39. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7:847-54.
40. Ou JN, Torrisani J, Unterberger A, Provencal N, Shikimi K, Karimi M, et al. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. Biochem Pharmacol 2007; 73:1297-307.
41. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002; 21:5400-13.
42. Guo Y, Pakneshan P, Gladu J, Slack A, Szyf M, Rabbani SA. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. J Biol Chem 2002; 277:41571-9.
43. Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast car- cinoma and ovarian carcinoma. Cancer Res 2003; 63:664-73.
44. Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C, et al. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 2005; 65:7635-43.
45. VanHouten JN, Yu N, Rimm D, Dotto J, Arnold A, Wysolmerski JJ, et al. Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene. J Clin Endocrinol Metab 2006; 91:580-3.
46. Liu Y, Kuick R, Hanash S, Richardson B. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol 2009; 130:213-24.
47. Tost J, El Abdalaoui H, Gut IG. Serial pyrose-quencing for quantitative DNA methylation analysis. Biotechniques 2006; 40:721-6.
48. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980; 20:85-93.
49. Gallwitz WE, Guise TA, Mundy GR. Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo. J Clin Invest 2002; 110:1559-72.
50. Newell-Price J, King P, Clark AJ. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression. Mol Endocrinol 2001; 15:338-48.